Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03735238 · ClinicalTrials.gov registry record
Implementing the Decision-Aid for Lupus (IDEAL Strategy)
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 1,895
- Enrollment target
NCT03735238 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1,895 participants.
The verdict
NCT03735238 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 1,895 participants
- Enrollment target
Study Summary
The study will attempt to put into practice a shared decision making (SDM) strategy, using an individualized, computerized decision- aid (DA) for Systemic lupus erythematosus (SLE).
Interventions
- OTHER SMILE Computerized Decision-Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,895 participants |
| Start Date | 2018-12-15 |
| Est. Completion | 2025-06-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03735238
The ClinicalTrials.gov registry entry for NCT03735238 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,895 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SMILE Computerized Decision-Aid is the first listed.
NCT03735238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03735238 about?
NCT03735238 is a clinical study titled "Implementing the Decision-Aid for Lupus (IDEAL Strategy)". The study will attempt to put into practice a shared decision making (SDM) strategy, using an individualized, computerized decision- aid (DA) for Systemic lupus erythematosus (SLE).
What is the current status of trial NCT03735238?
This trial is currently completed. The enrollment target is 1,895 participants. The study started on 2018-12-15. Estimated completion is 2025-06-10.
What interventions are being tested in trial NCT03735238?
The interventions under investigation include: SMILE Computerized Decision-Aid (OTHER).
Who is sponsoring clinical trial NCT03735238?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.